News

Michel Sadelain Appointed Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy

Columbia University — New York, NY (September 30, 2024) — Michel Sadelain, MD, PhD, has been named the inaugural director of the Columbia Initiative for Cell Engineering and Therapy (CICET) and director of the Cancer Cell Therapy Initiative in the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center. “Today’s announcement underscores Columbia’s … Continued

Read More

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for its 2025 Prize for Rising Stars in Cancer Research

September 23rd, 2024 (The Pershing Square Foundation, Business Wire, New York, NY): The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2025 Pershing Square Sohn Cancer Prize (formerly known as the Pershing Square Sohn Prize for Young Investigators in Cancer Research). The prize of $250,000 per year for … Continued

Read More

PRESS RELEASE: THE PERSHING SQUARE SOHN PRIZE AWARDED TO FIVE EMERGING LEADERS IN CANCER RESEARCH

THE PERSHING SQUARE SOHN PRIZE AWARDED TO FIVE EMERGING LEADERS IN CANCER RESEARCH The Pershing Square Foundation Has Committed More Than $43 Million to 71 Scientists in the Greater New York Area to Support High-Risk, High-Reward Cancer Research NEW YORK, JUNE 4, 2024 (Business Wire) – The Pershing Square Sohn Cancer Research Alliance today announced … Continued

Read More

Pancreatic cancer hijacks a brain-building protein

CSHL (February 14, 2024) — Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of California, Davis have reached a new breakthrough in pancreatic cancer research—eight years in the making. It could help slow the disease’s deadly spread. In 2017, as a postdoc in CSHL’s Tuveson lab, Chang-il Hwang and collaborators from the Vakoc lab uncovered … Continued

Read More